Pamidronate reduces bone loss after allogeneic stem cell transplantation. | J Clin Endocrinol Metab;91(10): 3835-43, 2006 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Pamidronate reduces bone loss after allogeneic stem cell transplantation.

Grigg, A P; Shuttleworth, P; Reynolds, J; Schwarer, A P; Szer, J; Bradstock, K; Hui, C; Herrmann, R; Ebeling, P R.

Affiliation

Grigg AP; Department of Medicine, University of Melbourne, Western Hospital, Footscray 3011, Australia.

J Clin Endocrinol Metab ; 91(10): 3835-43, 2006 Oct.

Article in En | MEDLINE | ID: mdl-16835281

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Stem Cell Transplantation / Diphosphonates Type of study: Clinical_trials / Etiology_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2006 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Stem Cell Transplantation / Diphosphonates Type of study: Clinical_trials / Etiology_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2006 Document type: Article Affiliation country: Country of publication: